Home / Archive / Clinical Trials / Coronary Heart Disease / Alpha Lipoic Acid Clinical Study

For Johns Hopkins Employees

Diseases, Conditions & TreatmentsSpecialty AreasExpert TeamsHistoryClinical TrialsTraining Programs
Hopkins Heart Home
Refer a Patient
Make an Appointment
Media and Press
Make a Gift
Alpha Lipoic Acid Clinical Study
Principal Investigator Name:
Pamela Ouyang, MBBS
 
Study Coordinator Name:Melanie Herr, RN

Contact Phone:

(410) 550 - HART (4278)
Study Coordinator


Contact E-mail:mherr@jhmi.edu
Study Coordinator

Study Short Title:TACT Study

Study Long Title:

Trial To Assess Chelation Therapy


IRB Number:HBV 03-06-19-01

Funding Source:National Institutes of Health

Summary of Trial:

Volunteers are needed for a
CHELATION THERAPY Study
Sponsored by the National Institutes of  Health

Chelation (key-LAY-shun)Therapy is being studied as a potential treatment for coronary heart disease in people who have had a previous heart attack.

If you participate in this study, you will receive 28 months of treatment and up to 32 months of follow-up. You will not be charged for participating in this study and will receive vitamin and mineral supplements.


Inclusions:

We are seeking volunteers  50 years  or older who have survived a heart attack.


Exclusions:

You must not have smoked for the past 3 months and not have had chelation therapy for at least the last 5 years.


Clinical Trial Site:Johns Hopkins Bayview Medical Center
4940 Eastern Ave
Bldg B room 420
Baltimore, MD 21224

Compensation for Participating?No

Start Date:January 2004

Anticipated End Date:January 2008

Maps & Directions    |    Privacy Policy    |    Intranet    |    Media Inquiries

© 2007 Johns Hopkins Medicine, All Rights Reserved.